Maternal venous procalcitonin levels do not correlate with umbilical cord blood and venous blood concentrations in the neonate
- PMID: 17140295
- DOI: 10.1515/JPM.2006.109
Maternal venous procalcitonin levels do not correlate with umbilical cord blood and venous blood concentrations in the neonate
Abstract
Background: To compare procalcitonin (PCT) concentrations between maternal blood and levels in umbilical cord or venous blood of neonates who were born with or without infection.
Methods: Forty-six women with singleton pregnancies, complicated by premature rupture of membranes, preterm delivery and/or chorioamnionitis, were enrolled in this study. The study group comprised 15 patients and their infected newborns. The control group consisted of 31 women and their healthy newborns. We compared PCT concentrations between maternal, umbilical cord and neonatal serum, in both study and control groups. Additionally, PCT levels were compared between the corresponding compartments.
Results: PCT concentrations in the umbilical cord and venous blood in infected newborns, but not in non-infected neonates, were significantly higher than maternal serum PCT levels. PCT concentrations of mothers who delivered infected newborns were comparable to those in the controls. However, PCT concentrations in the umbilical cord and in the venous blood of the infected newborns were higher than in healthy newborns.
Conclusion: Measurement of maternal PCT concentration during labor does not contribute to early prediction of infection in the neonate. However, umbilical cord PCT concentrations, as well as its neonatal venous levels on the second day of life, seem to be related to intrauterine infection, and may be a useful tool in the diagnosis of early neonatal infection.
Similar articles
-
[Procalcitonin as a marker of perinatal infection in newborn--preliminary data].Ginekol Pol. 2002 Aug;73(8):727-31. Ginekol Pol. 2002. PMID: 12369301 Polish.
-
Umbilical cord blood procalcitonin and C reactive protein concentrations as markers for early diagnosis of very early onset neonatal infection.Arch Dis Child Fetal Neonatal Ed. 2006 Jan;91(1):F65-6. doi: 10.1136/adc.2005.074245. Arch Dis Child Fetal Neonatal Ed. 2006. PMID: 16371391 Free PMC article.
-
Maternal plasma procalcitonin concentrations in pregnancy complicated by preterm premature rupture of membranes.Mediators Inflamm. 2007;2007:35782. doi: 10.1155/2007/35782. Mediators Inflamm. 2007. PMID: 17710246 Free PMC article.
-
[Prediction of maternofetal infection in preterm premature rupture of membranes: serum maternal markers].Gynecol Obstet Fertil. 2011 May;39(5):302-8. doi: 10.1016/j.gyobfe.2010.11.006. Epub 2011 Apr 22. Gynecol Obstet Fertil. 2011. PMID: 21515086 Review. French.
-
[Procalcitonin, a new marker for bacterial infections].Ann Biol Clin (Paris). 2000 Jan-Feb;58(1):49-59. Ann Biol Clin (Paris). 2000. PMID: 10673614 Review. French.
Cited by
-
The diagnostic utility of procalcitonin, interleukin-6 and interleukin-8, and hyaluronic acid in the Norwegian consensus definition for early-onset neonatal sepsis (EONS).Infect Drug Resist. 2018 Mar 8;11:359-368. doi: 10.2147/IDR.S155965. eCollection 2018. Infect Drug Resist. 2018. Retraction in: Infect Drug Resist. 2018 Jun 12;11:889. doi: 10.2147/IDR.S175799. PMID: 29563816 Free PMC article. Retracted.
-
The diagnostic accuracy of umbilical cord procalcitonin in predicting early-onset neonatal infection.PLoS One. 2025 Jan 16;20(1):e0316987. doi: 10.1371/journal.pone.0316987. eCollection 2025. PLoS One. 2025. PMID: 39821188 Free PMC article.
-
Risk of early-onset neonatal infection with maternal infection or colonization: a global systematic review and meta-analysis.PLoS Med. 2013 Aug;10(8):e1001502. doi: 10.1371/journal.pmed.1001502. Epub 2013 Aug 20. PLoS Med. 2013. PMID: 23976885 Free PMC article.
-
Umbilical blood biomarkers for predicting early-onset neonatal sepsis.World J Pediatr. 2012 May;8(2):101-8. doi: 10.1007/s12519-012-0347-3. Epub 2012 May 10. World J Pediatr. 2012. PMID: 22573419 Review.
-
Prediction of histological chorioamnionitis and neonatal and infantile outcomes using procalcitonin in the umbilical cord blood and amniotic fluid at birth.J Obstet Gynaecol Res. 2018 Apr;44(4):630-636. doi: 10.1111/jog.13573. Epub 2018 Jan 5. J Obstet Gynaecol Res. 2018. PMID: 29315994 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical